Log In
Print this Print this

Comtan, entacapone

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCatechol-O-methyl-transferase (COMT) inhibitor that inhibits breakdown of levodopa
Molecular Target Catechol-O-methyl-transferase (COMT)
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation
PartnerOrion Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today